What is the Current Share Price of Rekvina Labs Ltd?
- Answer Field
-
Rekvina Labs Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 22.30 as on Feb 13 2026 03:15 PM.
As of the latest trading session, REKVINA LABORATORIES LTD. share price is currently at ₹22.3, which is up by ₹0.42 from its previous closing. Today, the stock has fluctuated between ₹22.30 and ₹22.31. Over the past year, REKVINA LABORATORIES LTD. has achieved a return of [-]%. In the last month alone, the return has been 214.97%.
| Particulars | DEC 2025 (Values in Cr) |
|---|---|
| Revenue | 0.35 |
| Operating Expense | 0.47 |
| Net Profit | -0.12 |
| Net Profit Margin (%) | -34.28 |
| Earnings Per Share (EPS) | -0.21 |
| EBITDA | -0.12 |
| Effective Tax Rate (%) | 0.00 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | 28.58 | 12.37 | 1.48 | 219.02 | 23.12 / 52.00 |
| BLISS GVS PHARMA LTD | 217.80 | 20.82 | 2.03 | 2304.08 | 105.05 / 225.00 |
| CIPLA LTD | 1330.85 | 22.61 | 3.26 | 107503.49 | 1283.00 / 1672.20 |
| FERMENTA BIOTECH LIMITED | 310.90 | 10.34 | 2.34 | 915.01 | 219.00 / 399.00 |
| GLAXOSMITHKLINE PHARMA LT | 2593.90 | 43.69 | 25.73 | 43942.23 | 1968.00 / 3515.95 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | 28.58 | 23.24 | 3.98 | 219.02 | 23.12 / 52.00 |
| AMRUTAJAN HEALTH LTD | 632.15 | 31.61 | 5.34 | 1827.59 | 548.05 / 789.95 |
| ASTRAZENECA PHARMA IND LT | 8878.75 | 106.70 | 27.78 | 22196.88 | 6501.60 / 10653.05 |
| BLISS GVS PHARMA LTD | 217.80 | 29.67 | 2.08 | 2304.08 | 105.05 / 225.00 |
Choose a Plan That Suits Your Goals and Needs
Subscription Charge : FREE
Professional Pack
Subscription Charge : ₹2,500 Yearly
Signature
Rekvina Labs Limited was incorporated on 1st November 1988. From a small domestic company at inception in middle of 80's, Rekvina has grown formidably to be an integrated, Indian pharmaceutical company with sales in excess of Rs 20 Crore. It is registered in England and Wales as a Public Limited Company. The Company is a Quality producer of Pharmaceutical formulations for its customer as per their specific requirements. It provide contract research and manufacturing services to customers.
The Company is mainly engaged in manufacturing and marketing of pharmaceutical products. It presently operates into one business segment i.e. Copper Extrusion. The Company had launched a new product 'REKSEAL', a tissue adhesive for wound closure from the market in 1999-2000. Though there was persistent recessionary trend in the pharmaceutical industry there is a decrease in the turnover of the Company which affected the. net worth of the Company adversely.
In 2019-20, there was an overall slowdown in the economy. The Company incurred losses over a couple of years. The Company is focusing on strengthening its core business of manufacturing and marketing formulations. Research and Development (R&D) initiatives have been accelerated to improve cost competitiveness and ensure compliance with global regulatory requirements. Cost optimization, efficient resource utilization, and strong management control are being emphasized across all operations.
Rekvina Labs Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 22.30 as on Feb 13 2026 03:15 PM.
The market cap of Rekvina Labs Ltd for NSE ₹ 0.00 & for BSE ₹ 13.40 as on Feb 13 2026 03:15 PM.
The 52 Week High and Low of Rekvina Labs Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 22.31 and ₹ 6.75.
The 1 year returns on the stock has been 0.00%.
As on Feb 13 2026 03:15 PM the price-to-earnings (PE) ratio for Rekvina Labs Ltd share is -57.18.
As on Feb 13 2026 03:15 PM, the price-to-book (PB) ratio for Rekvina Labs Ltd share is -1.24.
You can trade in Rekvina Labs Ltd shares with Bajaj Broking by opening a demat account.
To buy Rekvina Labs Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Rekvina Labs Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found
Freedom Pack